NDC11 71209007805
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71209-0078-05 | 71209-0078 |
| 71209-0078-5 | 71209-0078 |
| 71209-078-05 | 71209-078 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olanzapine | OLANZAPINE | Cadila Pharmaceuticals Limited | 2ae07ad4-4e58-4740-9f02-035ec061fefc | 2025-03-11 | Boxed warning, Warnings, Adverse reactions | 71209-078-05 71209-078 71209007805 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.